Detection of living cells that express AP1 using a fluorolabeled DNA probe  by Shimokawa, Noriaki & Miura, Mitsuhiko
FEBS Letters 388 (1996) 16-20 FEBS 17098 
Detection of living cells that express AP1 using a fluorolabeled DNA 
probe 
Noriaki Shimokawa*, Mitsuhiko Miura 
Department of Physiology 1st Division, Gunma University School of Medicine, 3-39-22 Showa-machi, Maebashi City 371, Japan 
Received 29 March 1996 
devised method using a fluorescent probe is feasible for the Abstract Activator protein 1 (AP1) is a complex of Fos and 
isolation of living APl-expressed neurons. Jun, and it regulates the transcription of genes possessing the 
APl-binding sequence. The purpose of this study was to detect 
living cells that express AP1 after stimulation with a tumor 2. Materials and methods 
promoter. The Fos and dun components of AP1 were induced 
rapidly and transiently in PCI2  cells following the addition of 2.1. Chemicals 
phorbol ester (phorbol 12-myristatc 13-acetate, PMA). The Lipofectamine r agent (DOSPA/DOPE 3:1, mol/mol), a polycatio- 
DNA fragment containing the APl-bindlng sequence was nic liposome, for DNA transfection was purchased from Life Tech- 
combined with ethidium bromide, which was used as a fluorescent nologies (Gaithersburg, MD). Phorbol 12-myristate 13-acetate (PMA) 
probe. The probe was transfected into the cells using cationic as a tumor promoter was obtained from Wako Pure Chemical Co. 
(Osaka, Japan). The fluorescent dye ethidium bromide was obtained 
liposomes. Fluorescence in the transfected cells was observed from Sigma Chemical Co. (St. Louis, MO). Other reagents were pur- 
using a fluorescence microscope. The nuclei of transfected cells chased from the indicated sources: Dulbecco's Modified Eagle's Med- 
emitted strong fluorescence in the presence of PMA, whereas ium (DMEM) and L-glutamine from Nissui Pharmaceutical Co. Ltd. 
weak fluorescence was retained in the cytoplasm in its absence. (Tokyo, Japan); deoxycytidine 5'-[c~-32P]triphosphate ([32P]dCTP; 110 
The former phenomenon is evidence that AP1 combined with the TBq/mmol) and nylon membranes (Hybond N +) for Northern hybri- 
fluorescent probe was transported into the nuclei. This study dization from Amersham (Bucks, UK); anti-c-Fos and c-Jun antisera 
suggests that such a fluorolabeling method is feasible to detect from Cambridge Research Biochemicals (Cheshire, UK); polyvinyli- 
living APl-expressed neurons, dene difluoride (PVDF) membranes from Millipore (Bedford, MA); 
ABC reagents from Vector Labs. (Burlingame, CA); restriction en- 
zymes (ApaI and SacI) and DNA polymerase from Takara Shuzo Co. 
Key words: Activator protein 1; APl-binding sequence; Ltd. (Kyoto, Japan). 
Fluorescent probe; Transfection; Living cell; Detection 
method 2.2. Cell culture and PMA treatment 
PC12 rat pheochromocytoma cells, from a line initiated by Greene 
and Tischler [10], were kindly supplied by the Riken Cell Bank (Tsu- 
kuba, Japan). PC12 cells were grown in DMEM supplemented with 
1. Introduction 10% heat-inactivated horse serum (HS), 5% fetal bovine serum (FBS), 
4 mM L-glutamine and 60 [tg/ml kanamycin in tissue culture dishes. 
Activator protein 1 (AP1), a nuclear transcription factor, is The tissue culture dishes had previously been treated with rat-tail 
collagen and washed with serum-free DMEM. For experiments, the 
a complex formed through leucine zipper motifs [1]. The ma- cells were plated at a density of 2x105 cells per 35 mm dish and 
jor components of the complex are products of the c-los and incubated at 37°C in an atmosphere of 95% air/5% CO2. 24 h after 
c-jun protooncogenes, i.e. the c-Fos and c-Jun proteins. The plating, cells were stimulated with PMA for various times. PMA (5 
complex binds to the palindromic APl-binding sequence mM) was kept as a stock solution in dimethyl sulfoxide (DMSO) and 
added directly to the culture dish to a final concentration of 100 nM. 
TGAC/GTCA [2,3] and regulates the transcription of genes Control dishes contained appropriate concentrations of DMSO. After 
that have the APl-binding sequence [4,5]. Recently, several mixing by gently swirling, cells were immediately returned to the cul- 
investigators howed that the components of AP1 were in- ture incubator. 
duced rapidly and transiently within neurons following synap- 
tic activation [6-8] and pharmacological stimulation [9]. 2.3. Northern blot analysis 
Total cellular RNA from cultured PC12 cells was prepared by the 
Since the APl-expressed neurons always lost viability dur- guanidinium thiocyanate method [11]. Northern hybridization was 
ing immunohistochemical and biochemical procedures uch as performed as described previously [12]. RNA (10 I.tg/lane) was elec- 
fixation and homogenization of cells, the isolation and culture trophoresed in 1.2% agarose denaturing els containing 2.2 M for- 
of living APl-expressed neurons have yet to be studied. This maldehyde. Separated RNAs on the gels were transferred to nylon 
membranes by alkaline blotting. Complementary DNA (cDNA) of c- urged us to establish an appropriate marking method for liv- fos (obtained from the Japanese Cancer Research Resources Bank) 
ing APl-expressed neurons. Since PC12 cells readily differenti- and c-jun (obtained from the Riken Gene Bank) were labeled with 
ate into sympathetic neurons by induction of nerve growth [z2P]dCTP using random primers with DNA polymerase Klenow frag- 
factor (NGF), PC12 cells are frequently used as a model sys- ment [13]. These radioactive probes were used for the detection of 
RNAs on blots. The membrane was hybridized in buffer solution tern for the culture of neurons [10]. In this study, we tried to 
with labeled cDNA at 42°C for 16 h. After hybridization, the mem- 
detect living PC12 cells that expressed AP1 following stimula- brane was washed, and the blot was used for the detection of radio- 
tion of a tumor promoter. The results showed that our newly activity using a Fujix BAS-2000 Bio-Imaging Analyzer (Fuji Photo 
Film Co. Ltd., Japan). 
*Corresponding author. Fax: (81) (272) 20-7926. 
2.4. Western blotting 
Abbreviations: DOSPA, 2,3-dioleyloxy-N-[2(sperminecarboxami- Cells were harvested at 2 h after the addition of PMA. Nuclear 
do)ethyl]-N,N-dimethyl-l-propanaminium trifluoroacetate; DOPE, extracts for Western blotting were prepared according to the method 
dioleoylphosphatidylethanolamine of Dignam et al. [14]. Extracts from the PC12 cells were subjected to 
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SDS-PAGE [15], and the proteins were transferred to a PVDF mem- 
brane by electroblotting. Membranes were blocked with 5% bovine 
serum albumin and incubated with appropriate dilutions of primary Time 0 .5 1 2 4 
antibody (anti-c-Fos or c-Jun antiserum) at 4°C for 12 h. After in- (h) 
cubation, membranes were incubated with biotinylated secondary A ~ ~% ~ ~'~ ~ 
antibody, incubated in ABC solution, and then treated with diamino- 2.8-  
benzidine plus nickel chloride (DAB-Ni) solution containing 0.003% !{~%'s" ...... ~;<~ ~,~:~ .~ . . . .  ~ ~ 
'~ ~ . . . . .  ~c-fos mRNA H202. 2.1 - 
2.5. DNA-protein binding test . . . . . . .  
The binding of PC12 nuclear extracts to the consensus APl-binding 
sequence was examined as follows [16]. A 96 bp ApaI-SacI fragment 
containing the APl-binding site was excised from the c-jun/CAT re- I~  
TheP°rter f agment gen  (c-jun-730CAT;(150 ~tg) was conjugated°btained frOmwith Rikenl00 IxgGeneof thidiumBank) bro-[17]" D 4.2 -!~:~(~;~.~:~<~,~'~':,.i~;~,~L~<~,~:,<~ ~ ! ' 7( : ' ;~!' i~!(~'~!~'i~~!+~  : ~ . . . . . . . "   : '~ i' , :   : :~': " ' ,  ,+ , ::., ;j~,¢: 
mide, a fluorescent dye. The unincorporated ethidium bromide was ~ . c-jun mRNA 
removed from fluorolabeled DNA fragments by precipitation with 2 .8-  
ethanol. Binding reaction mixtures (10 ~tl) contained 25 I.tg PC12 
nuclear protein, 25 mM HEPES-KOH, 0.5 mM EDTA-NaOH, 50 ~°~'~'~ 
mM KC1, 0.75 mM phenylmethylsulfonyl fluoride (PMSF), 0.75 
mM dithiothreitol (DTT), 10% glycerol, and 150 ng of fluorolabeled 
AP1 probe, incubation being performed at room temperature for 20 ~. f  
min. The reaction mixture was subjected to electrophoresis through 
7% polyacrylamide gels containing 50 mM Tris, 50 mM boric acid 28S - 
and 1.25 mM EDTA. DNA-protein complexes in the gel were de- 
tected by illumination with UV light (wavelength, 302 rim). The spe- 18S - 
cificity of the binding complex was demonstrated bycompetition with 
a 20-fold excess of non-fluorolabeled probe. Fig. 1. Time course of c-fos (A) and c-jun (B) mRNA expression in 
PMA-treated PC12 cells. Cells were treated with PMA (100 riM) for 
2.6. Transfection the indicated times. Northern blotting was performed as described 
The fluorolabeled probes were introduced into cells using cationic in Section 2. The arrowhead indicates hybridizing bands correspond- 
lipids, lipofectamine reagent, following the manufacturer's recom- ing to mRNA encoding c-Fos or c-Jun. The two ribosomal RNAs 
mended protocol with minor modifications. Fluorolabeled DNA stained with ethidium bromide are shown as control (C), and posi- 
probes (50 I.tg) and lipofectamine (50 I.tg) were separately diluted in tions of standard molecular mass (kb) are indicated on the left. 
0.1 ml 4% HS, 2% FBS, and antibiotic-free DMEM (low-serum ed- 
ium), then mixed and incubated for 1 h at room temperature. Low- 
serum medium (0.8 ml) was added, and the entire mixture was added 
to the ceils. Subsequently, cells were treated with PMA as described in detected by screening using each antibody, whereas neither c- 
Section 2.2. The ceils were then transferred to a 37°C incubator for Fos nor c-Jun was detected in untreated cells. This result 
8 h. Fluorescence in the transfected cells was observed under a fluor- reflected not only the elevation of c-fos and c-jun mRNAs 
escence microscope (excitation wavelength, 488 nm). Viability of the 
transfected cells was estimated by trypan blue exclusion, but also the accumulation of Fos and Jun in the nuclei. 
To determine whether AP1 proteins bind to the fluorola- 
2.7. Image processing beled APl-binding sequence and whether the complexes are 
Transfected cells were photographed using Fujichrome color slide detectable by fluorescence, we undertook a DNA-protein 
film. The slides and results of the blotting and binding test were binding test, the results of which are illustrated in Fig. 3. 
scanned into digital memory using scanners, and arranged in compo- 
sites using Photoshop software (Adobe Inc., Mountain View, CA). Lane 1 shows a fluorescent band of free probes (96 bp) to 
which nuclear extracts from the untreated PC12 cells did not 
bind. Lane 2 demonstrates the appearance of a high molecular 
3. Results weight fluorescent band, a complex of fluorolabeled probes 
and AP1 in nuclear extracts from PMA-treated PC12 cells. 
To determine whether the expression of c-fos and c-jun is Lane 3 shows that a high molecular weight fluorescent band 
induced by PMA stimulation, we carried out Northern blot disappeared when non-fluorolabeled cDNA was added to the 
analysis of the expression of c-fos and c-jun mRNAs in PC12 nuclear extracts from PMA-treated PC12 cells. 
cells following stimulation with PMA. We prepared RNA To visualize the living cells that expressed AP1 protein, we 
blots that contained cytoplasmic RNA obtained from the introduced the fluorolabeled probes into the PC12 cells. When 
PMA-treated PC12 cells. The blots were hybridized with a PMA was added to the cell culture, it was observed that the 
labeled fragment of c-fos or c-jun cDNA under conditions nuclei of PC12 cells emitted strong fluorescence (Fig. 4C). The 
of high stringency. Fig. 1A shows that the level of c-fos average percentage of the cell population that emitted fluor- 
mRNA (2.2 kb) increased markedly 1 h after the addition escence was about 40% (8 × 104 emitting cells per 2× 10~). 
of PMA, but returned to a low level 2 h after PMA addition. Since the fluorescent cells were not stained with trypan blue, 
These observations were consistent with the previous report they may be living cells. When an organic solvent for PMA 
[18]. Fig. 1B shows that two c-jun transcripts (approx. 3 and (DMSO) was added, weak fluorescence was found only in the 
3.5 kb) increased 1 h after the addition of PMA and gradually cytoplasm as shown in Fig. 4A. 
decreased, maintaining a high level until 4 h. This suggests 
that the c-jun gene be autoregulated by the binding of its own 4. Discussion 
gene product to an AP1 sequence in the c-jun promoter [19]. 
Moreover, the expression of c-Fos and c-Jun proteins in the To detect cells that express Fos, Jun and AP1, several meth- 
nuclei of PMA-treated PC12 cells was monitored by Western ods have been used. These include immunohistochemical tech- 
blot analysis (Fig. 2). c-Fos (62 kDa) and c-Jun (39 kDa) were niques [8,20], Western blotting [20,21], immunoprecipitation 
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anti c-Fos anti c-Jun Most of the PC12 cells expressed AP1 with PMA (100 nM, 
data not shown), while the average percentage of the cell 
1 2 1 2 population emitting fluorescence was as low as 40%. Since 
the instruction manual for the cationic liposomes hows that 
(kDa) . . . .  nucleic acids are introduced into 3040% of PC12 cells with ! 
the help of the liposomes, it is reasonable to suppose that the 
emitting cells make up 40% of the population. i !i l Montminy et al. [30] reported that a DNA element subserv- 
92-- ing induction by adenosine Y,5'-monophosphate (cAMP) to 
some mammalian gene promoters (cAMP-responsive element; 
CRE) is different from the APl-binding sequence, because a
i 69-- . . . .  single nucleotide, guanylic acid, is inserted into a sequence 
~Ic -Fos  TGACGTCA of the latter [30]. Curran and Franza [31] re- 
ported that a CRE-binding protein (CREB) binds to the AP1 
sequence but the binding affinity of the CREB and AP1 is 5- 
10-fold less than that of the CREB and CRE. These data 
46-- suggest hat our newly devised method may be applicable to 
i 4 c-Jun the detection of living cells that express various DNA-binding 
: proteins by replacing the DNA-binding sequence. 
...... In conclusion, this study has shown that the combination of
a fluorescent probe with the transfection procedure is a useful i!ii 
30-- technique to detect living cells that express AP1. 
Fig. 2. Expression of c-Fos and c-Jun in PMA-treated PC12 cells. 
Cells were treated with PMA (100 nM) for 2 h. Nuclear proteins 
were analyzed by SDS-PAGE followed by immunoblotting with 1 2 3 
anti-c-Fos or c-Jun antibody. The antigenic signals were amplified 
with an avidin-biotin complex and visualized by DAB-Ni treatment. 
Lanes: 1, nuclear extracts from untreated cells; 2, nuclear extracts 
from PMA-treated cells. The molecular masses (kDa) of protein 
markers (Rainbow marker, Amersham) are indicated on the left. (bp) 
. AP1 
[22,23] and gel mobility shift assays [17,21]. These techniques 
involve the procedures of sectioning and/or homogenizing 
cells which do not allow cells to survive. Our newly devised 
method, however, allows APl-expressed cells to survive. This 
success is possibly due to two merits. First, we used ethidium 
bromide for labeling DNA. Ethidium bromide is a basic fluor- 
escent dye suitable for staining nucleic acids in living cells [24]. 
Ethidium bromide intercalates between the stacked bases of 
nucleic acids, and fluoresces with a wavelength of 590 nm. 
Using the ethidium bromide-labeled probe, we succeeded in 
detecting AP1 in non-denaturing polyacrylamide g ls. Second, 
we used liposomes to transfect cells on account of their high 
efficiency and low toxicity to cells. With the help of liposomes, 
the fluorescent probes containing the APl-binding sequence 
were successfully introduced into cells and bound to AP1 
formed in the cytoplasm [25]. AP1 possesses nuclear localiza- 150  -- 
tion signals (NLS) that attract proteins into the nuclei [26]. 
This is the reason why the fluorescent probes containing the 
APl-binding sequence accumulate in the nuclei. ~ probes 
Several investigators have reported that the expression of l l_- 
AP1 is depressed in most neurons including PC12 cells under 75  / 
unstimulated conditions [8,20,27]. Acute stimulation, how- Fig. 3. Detection of complex of fluorolabeled DNA probe and AP1 
ever, elevates mRNAs of c-fos and c-jun to a peak 30 min protein. PC12 cells were treated with PMA (100 nM) for 2 h. The 
after the onset of stimulation [28,29], and ultimately the pro- reaction mixture containing the nuclear proteins and fluorolabeled 
duction of Fos and Jun proteins reaches a maximum 1-1.5 h DNA probe was incubated, electrophoresed and then exposed to 
after the onset of stimulation and persists for 2-6 h [28,29]. UV. Lanes: 1, mixture of nuclear extract from untreated cells and 
fluorolabeled probe; 2, mixture of nuclear extract from PMA-treat- 
These observations are consistent with the results of this ed cells and fluorolabeled probe; 3, mixture of nuclear extract from 
study, since the fluorescence in cellular nuclei began 8 h after PMA-treated cells and non-fluorolabeled probe. The molecular 
PMA stimulation, masses of nucleic acids (bp) are indicated on the left. 
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A B 
C D 
Fig. 4. Fluorescence observation of PC12 transfected with the APl-binding sequence. PC12 cells were treated with PMA (100 nM) for 8 h after 
transfection of fluorolabeled probes. (A) Cells without PMA treatment. (B) Bright field of (A). (C) Cells with PMA treatment. (D) Bright field 
of (C). 
Acknowledgements: The authors would like to thank Dr. J. Okada for [12] Shimokawa, N. and Yamaguchi, M. (1993) FEBS Lett. 316, 79- 
his excellent technical support. This work was supported in part by a 84. 
Grant-in-Aid for Encouragement of Young Scientists from the Min- [13] Feinberg, A. and Vogelstein, B. (1983) Anal. Biochem. 132, 6-13. 
istry of Education, Japan to N.S. [14] Dignam, J.D., Lebovitz, R.M. and Roeder, R.G. (1983) Nucleic 
Acids Res. 11, 1475-1489. 
Referenees [15] Laemmli, U.K. (1970) Nature 227, 680-685. 
[16] Chodosh, L.A. (1988) in: Current Protocols in Molecular Biol- 
ogy (Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., 
[1] Turner, R. and Tjian, R. (1989) Science 247, 1689-1694. Seidman, J.G., Smith, J.A. and Struhl, K. eds.) pp. 12.2.1 
[2] Bohmann, D., Bos, T.J., Admon, A., Nishimura, T., Vogt, P.K. 12.2.10, Greene Publishing Associates and Wiley-Interscience, 
and Tjian, R. (1989) Science 238, 1386-1392. New York. 
[3] Lee, W., Mitchell, P. and Tjian, R. (1987) Cell 49, 741-752. [17] Kitabayashi, I., Chiu, R., Gachelin, G. and Yokoyama, K. 
[4] Mitchell, P. and Tjian, R. (1989) Science 245, 371-378. (1991) Nucleic Acids Res. 19, 649-655. 
[5] Sonnenberg, J.L., Rauscher, F.J., III, Morgan, J.I. and Curran, [18] Singh, K.R., Taylor, L.K., Campbell, X.Z., Fields, A.P. and 
T. (1989) Science 246, 1622-1625. Neet, K.E. (1994) Biochemistry 33, 542-551. 
[6] Dragunow, M. and Faull, R. (1989) J. Neurosci. Methods 29, [19] Angel, P., Hattori, K., Smeal, T. and Karin, M. (1988) Cell 55, 
261-265 875-885. 
[7] Dragunow, M. and Robertson, H.A. (1987) Nature 329, 441~,42. [20] Bing, G., Stone, E.A., Zhang, Y. and Filer, D. (1992) Brain Res. 
[8] Sagar, S.M., Sharp, F.R. and Curran, T. (1988) Science 240, 592, 57-62. 
1328-1331. [21] Rauscher, F.J., III, Sambucetti, L.C., Curran, T., Distel, R.J. and 
[9] Saffen, D.W., Cole, A.J., Worley, P.F., Christy, B.A., Ryder, K. Spiegelman, B.M. (1988) Cell 52, 471480. 
and Baraban, J.M. (1988) Proc. Natl. Acad. Sci. USA 85, 7795- [22] Curran, T., Miller, A.D., Zokas, L. and Verma, I.M. (1984) Cell 
7799. 36, 259-268. 
[10] Greene, L.A. and Tischler, A.S. (1976) Proc. Natl. Acad. Sci. [23] Curran, T., Gordon, M.B., Rubino, K.L. and Sambucetti, L. 
USA 73, 2424-2428. (1987) Oncogene 2, 79-84. 
[11] Chomczynski, P. and Sacchi, N. (1987) Anal. Biochem. 162, 156- 
159. 
20 N. Shimokawa, M. Miura/FEBS Letters 388 (1996) 16-20 
[24] Crissman, H.A. and Steinkamp, J.A. (1973) J. Cell Biol. 59, 766- [28] Morgan, J.I., Cohen, D.R., Hempstead, J.L. and Curran, T. 
771. (1987) Science 237, 192-197. 
[25] Nakabeppu, Y., Oda, S. and Sekiguchi, M. (1993) Mol. Cell. [29] Sharp, F.R., Sagar, S.M., Hicks, K., Lowenstein, D. and Hisan- 
Biol. 13, 4157-4166. ga, K. (1991) J. Neurosci. 11, 2321-2331. 
[26] LaCasse, E.C. and Lefebvre, Y.A. (1995) Nucleic Acids Res. 23, [30] Montminy, M.R., Sevarino, K.A., Wagner, J.A., Mandel, G. and 
1647-1656. Goodman, R.H. (1986) Proc. Natl. Acad. Sci. USA 83, 6682- 
[27] Wu, B., Fodor, E.J.B., Edwards, R.H. and Rutter, W.T. (1989) 6686. 
J. Biol. Chem. 264, 9000-9003. [31] Curran, T. and Franza, B.R. Jr., (1988) Cell 55, 395-397. 
